Boston Scientific
42°21′37.3″N 71°33′32.6″W Boston Scientific Corporation ("BSC"), incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM subcutaneous implantable defibrillator (S-ICD).
| Company type | Public |
|---|---|
| ISIN | US1011371077 |
| Industry | Medical device |
| Founded | June 29, 1979 in Watertown, Massachusetts |
| Founders | |
| Headquarters | Marlborough, Massachusetts, U.S. |
Key people | Michael F. Mahoney, Chairman and CEO Daniel Brennan, CFO |
| Revenue | US$12.68 billion (2022) |
| US$1.65 billion (2022) | |
| US$698 million (2022) | |
| Total assets | US$32.47 billion (2022) |
| Total equity | US$17.57 billion (2022) |
Number of employees | c. 51,000 (2022) |
| Website | bostonscientific |